60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.390
-0.040 (-2.80%)
Jun 9, 2026, 4:00 PM EDT - Market closed
SXTP Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SXTP stock have an average target of $3.70, which predicts a 166.19% increase from the current stock price of 1.39.
Price Target: $3.70 (+166.19%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 9, 2026.
Analyst Ratings
The average analyst rating for SXTP stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 20, 2026 |
| Ascendiant | Ascendiant | Buy Reiterates $11 → $4.2 | Buy | Reiterates | $11 → $4.2 | +202.16% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
900.00K
from 1.41M
Decreased by -36.13%
Revenue Next Year
1.60M
from 900.00K
Increased by 77.78%
EPS This Year
-3.45
from -11.13
EPS Next Year
-3.58
from -3.45
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,000,000 | ||
| Avg | 900,000 | ||
| Low | 800,000 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -29.0% | ||
| Avg | -36.1% | ||
| Low | -43.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -3.45 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |